Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention;Tratamiento antitrombótico y tipo de stent en pacientes con fibrilación auricular a los que se practica una intervención coronaria percutánea

Revista Espanola de Cardiologia

Volumn 66, Issue 1, 2013, Pages 12-16

  Ruiz Nodar, Juan M ^a   Marín, Francisco ^b   Lip, Gregory Y H ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

HEART ATRIUM FIBRILLATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; STENT;

EID: 84871724037     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.07.018     Document Type: Article

References (39)

1. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, and S. Ernst Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
2. M. Anguita, F. Worner, P. Domenech, F. Marín, J. Ortigosa, and J. Pérez-Villacastín Nuevas evidencias, nuevas controversias: análisis crítico de la guía de práctica clínica sobre fibrilación auricular 2010 de la Sociedad Europea de Cardiología Rev Esp Cardiol 65 2012 7 13
3. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
4. L.R.M. Friberg, and G.Y.H. Lip Net clinical benefit of warfarin in patients with atrial fibrillation Circulation 125 2012 2298 2307
5. M. Rodríguez-Mañero, A. Cordero, V. Bertomeu- González, J. Moreno-Arribas, V. Bertomeu-Martínez, and P. Mazón Impacto de los nuevos criterios para el tratamiento anticoagulante de la fibrilación auricular Rev Esp Cardiol 64 2011 649 653
6. M. Nabauer, A. Gerth, S. Limbourg, M. Oeff, P. Kirchhof, and A. Goette The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management Europace 11 2009 423 434
7. J.M. Ruiz-Nodar, A. Cequier, T. Lozano, F. Fernández Vázquez, I. Möller, and S. Abán Impacto del tipo de hospital en el tratamiento y evolución de los pacientes con síndrome coronario agudo sin elevación del ST Rev Esp Cardiol 63 2010 390 399
8. G.Y. Lip, K. Huber, F. Andreotti, H. Arnesen, K.J. Airaksinen, and T. Cuisset Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting Thromb Haemost 103 2010 13 28
9. D.P. Faxon, J.W. Eikelboom, P.B. Berger, D.R. Holmes, D.L. Bhatt, and D.J. Moliterno Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective Thromb Haemost 106 2011 572 584
10. K. Huber, K.J. Airaksinen, T. Cuisset, F. Marín, A. Rubboli, and G.Y. Lip Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe Thromb Haemost 106 2011 569 571
11. J.M. Ruiz-Nodar, F. Marín, J.A. Hurtado, J. Valencia, E. Pinar, and J. Pineda Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for bleeding risk and prognosis J Am Coll Cardiol 51 2008 818 825 (Pubitemid 351255616)
12. W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, and H. Bueno ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 32 2011 2999 3054
13. A. Fernández-Ortiz, M. Pan, F. Alfonso, F. Arós, J.A. Barrabés, and V. Bodí Comentarios a la guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología Rev Esp Cardiol 65 2012 125 130
14. J.M. Ruiz-Nodar, F. Marín, V. Roldán, J. Valencia, S. Manzano-Fernández, and L. Caballero Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv 5 2012 459 466
15. A. Rubboli, J. Kovacic, R. Mehran, and G.Y. Lip Coronary stent implantation in patients committed to long-term oral anticoagulation therapy Chest 139 2011 981 987
16. H.J. Zhao, Z.T. Zheng, Z.H. Wang, S.H. Li, Y. Zhang, and M. Zhong "Triple therapy" rather than "triple threat". A meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral antiacoagulant treatment Chest 139 2011 360 370
17. S. Manzano-Fernández, F.J. Pastor, F. Marín, F. Cambronero, C. Caro, and D.A. Pascual-Figal Increased major bleeding complications related to triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary artery stenting Chest 134 2008 559 567
18. 2 score Thromb Res 121 2007 347 352
19. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696 (Pubitemid 46842784)
20. P. Karjalainen, S. Vikman, M. Niemaela, P. Porela, A. Ylitalo, and M.A. Vaittinen Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment Eur Heart J 29 2008 1001 1010 (Pubitemid 351844686)
21. R. Rossini, G. Musumeci, C. Lettieri, M. Molfese, L. Mihaslcsik, and P. Mantovani Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy Am J Cardiol 102 2008 1618 1623
22. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
23. Z. Khurram, E. Chou, R. Minutello, G. Bergman, M. Parikh, and S. Naidu Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding J Invasive Cardiol 18 2006 162 164 (Pubitemid 44576090)
24. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, and G. Stankovic Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
25. M. Valgimigli, G. Campo, M. Monti, P. Vranckx, G. Percoco, and C. Tumscitz Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
26. The, ACTIVE, Writing Group on behalf of the, ACTIVE., Investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation CLopidogrel Trial with Irbesartan for prevention of Vascular Events ("ACTIVE"): a randomised controlled trial Lancet 367 2006 1903 1912
27. J.M. Ruiz-Nodar, F. Marín, J. Sánchez-Paya, J.A. Hurtado, J. Valencia-Martín, and S. Manzano-Fernández Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation Eur Heart J 30 2009 932 939
28. L. Fauchier, C. Pellegrin, A. Bernard, N. Clementy, D. Angoulvant, and G.Y.H. Lip Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries Am J Cardiol 110 2012 7 12
29. V. Pasceri, G. Patti, C. Pristipino, F. Pelliccia, D. Irini, and A. Varveri Safety of drug eluting stent in patients on chronic anticoagulation using long-term single antiaplatelet treatment with clopidogrel Catheter Cardiovasc Interv 75 2010 936 942
30. G.Y. Lip, F. Andreotti, L. Fauchier, K. Huber, E. Hylek, E. Knight European Heart Rhythm Association Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis Thromb Haemost 106 2011 997 1011
31. K. Thygesen, J.S. Alpert, H.D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
32. ClinicalTrials.gov. Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE) [citado 21 Jun 2012]. Disponible en: http://clinicaltrials.gov/ct2/show/NCT00776633?term=ISAR- TRIPLE&rank=1
33. ClinicalTrials.gov. WOEST (What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) [citado 21 Jun 2012]. Disponible en: http://clinicaltrials.gov/ct2/ show/NCT00769938?term=WOEST&rank=1
34. ClinicalTrials.gov. Anticoagulation in Stent Intervention (MUSICA-2) [citado 21 Jun 2012]. Disponible en: http://clinicaltrials.gov/ct2/show/ NCT01141153?term=MUSICA-2&rank=1
35. I. Ahrens, G.Y. Lip, and K. Peter New oral anticoagulant drugs in cardiovascular disease Thromb Haemost 104 2010 49 60
36. J.H. Alexander, R.D. Lopes, S. James, R. Kilaru, Y. He, P. Mohan APPRAISE-2 Investigators Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
37. J.L. Mega, E. Braunwald, S.D. Wiviott, J.P. Bassand, D.L. Bhatt, C. Bode ATLAS ACS 2-TIMI 51 Investigators Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
38. 12 inhibitors Thromb Haemost 105 Suppl. 1 2011 S75 S81
39. L. Wallentin, R.C. Becker, S.K. James, and R.A. Harrington The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome Thromb Haemost 105 2011 760 762